Friday, February 26, 2027

Methamphetamine-associated PAH:
Misclassified, Mislabeled, or Misunderstood?

Richard Channick, MD

Methamphetamine Use – A Global
Pandemic Hiding in Plain Sight

Nicholas Kolaitis, MD, MAS

Panel Discussion | Audience Q&A

Moderator: Lana Melendres-Groves, MD
Discussants: Richard Channick, MD;
Nicholas Kolaitis, MD, MAS;
Marc Simon, MD; John Kingrey, MD

In Defense of the 6-Minute Hall Walk

R. James White, MD

Agents Formerly Known as Vasodilators:
Antifibrotic Therapies for Vascular Disease

Bhuvin Buddhdev, MD

Artificial Intelligence in PH: Transforming Care
or Outpacing the Evidence

Hilary DuBrock, MD

Panel Discussion | Audience Q&A

Moderator: Sanjeev Raman, MBBS, MD
Discussants: R. James White, MD;
Bhuvin Buddhdev, MD;
Hilary DuBrock, MD; Daniel Lachant, MD

Clinical Research: Progress and Pipeline in PAH

Mardi Gomberg, MD

Clinical Research: Progress and Pipeline in ILD

Mary Beth Scholand, MD

Panel Discussion | Audience Q&A

Moderator: Nick H. Kim, MD
Discussants: Mardi Gomberg, MD;
Mary Beth Scholand, MD;
Rajan Saggar, MD; Jennalyn Mayeux, DNP

Exploring the BMP9/ALK1/Endoglin Axis:
A Therapeutic Crossroads for HHT and PAH

Moderator: Josanna Rodriguez-Lopez, MD
Discussants: Kevin Whitehead, MD; Paul Yu, MD

The Great Debate: Cpc-PH…Treating Left-Heart
Disease with PH Medications…Should we Stop Asking the Question?

Moderator: John Ryan, MD, MB Bch BAO
Peter Leary, MD – PRO
Vallerie McLaughlin, MD, FACC – CON

To Treat or Not to Treat: Borderline PH

Ioana Preston, MD – Treat
Libo Wang, MD – Do Not Treat

From Surviving to Thriving:
A Patient-Centered Approach to Managing PAH

Denise Sese, MD

PH and Pregnancy: Revisiting Risk, Counseling,
and Contemporary Outcomes

Anjali Vaidya, MD

Don't Wait to Escalate: Confronting Therapeutic Inertia in PH

Naomi Habib, MD

Panel Discussion | Audience Q&A

Moderator: Harrison Farber, MD
Discussants: Denise Sese, MD;
Anjali Vaidya, MD; Naomi Habib, MD